Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[Pretreatment and Posttreatment Evaluations of Circulating Tumor Cells（CTC）in Patients with Metastatic Breast Cancer]Mina Okabe, Uhi Toh, Nobutaka Iwakuma, et al.
The Kurume Medical Journal|February 5, 2014
The effect of starvation on blood stream cancer cell metastasis to the liver in rat after laparotomyTatsuya Muraoka, Kazuo Shirouzu, Hiroyuki Ozasa, et al.
Surgery Today|January 8, 2014
Primary breast peripheral T-cell lymphoma not otherwise specified: report of a caseDaisuke Muroya, Uhi Toh, Nobutaka Iwakuma, et al.
The Kurume Medical Journal|February 18, 2014
Effect of preoperative administration of methylpredonisolone and ulinastatin on tumor cell metastasis after surgical stressKazuya Momosaki, Nobuya Ishibashi, Shogo Yoshida, et al.
Breast Cancer (Tokyo, Japan)|July 6, 2013
Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil-oteracil potassium in metastatic and recurrent breast cancerHiroko Otsuka, Teruhiko Fujii, Uhi Toh, et al.
Cancer Science|June 5, 2020
Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancerUhi Toh, Sayaka Sakurai, Shuko Saku, et al.
Surgery Today|October 24, 2013
Usefulness of endoscopic breast-conserving surgery for breast cancerHiroki Takahashi, Teruhiko Fujii, Shino Nakagawa, et al.
Cancer Science|November 2, 2016
Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancerMina Okabe, Uhi Toh, Nobutaka Iwakuma, et al.
World Journal of Surgical Oncology|November 15, 2024
The effective duration of systemic therapy and the neutrophil-to-lymphocyte ratio predict the surgical advantage of primary tumor resection in patients with de novo stage IV breast cancer: a retrospective studyRie Sugihara, Hidetaka Watanabe, Shuntaro Matsushima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 21, 2016
[Development of Peptide Vaccines for Triple-Negative Breast Cancer Treatment]Uhi Toh, Shuko Saku, Mina Okabe, et al.
Pageof 4